share_log

啓明醫療-B:致登記股東之通知信函 - 2023年度報告之發布通知及回條

VENUS MEDTECH-B: Notification Letter to Registered Shareholders - Notice of Publication of 2023 Annual Report and Reply Form

Hong Kong Stock Exchange ·  Apr 29 09:07
Summary by Moomoo AI
啓明醫疗宣布其2023年度報告已於2024年4月30日發布,並可於香港交易所及公司網站上瀏覽。該報告提供中英文版本,以符合香港交易所無紙化上市制度及電子發布公司通訊的新規定。啓明醫療鼓勵股東透過電子方式接收未來的公司通訊,並提供個人化二維碼以便股東提供電郵地址。股東若未能於2024年5月15日前提供電郵地址,將被視為同意接收公司通訊的網上版本。公司也提供選項讓股東要求以印刷本形式接收公司通訊。
啓明醫疗宣布其2023年度報告已於2024年4月30日發布,並可於香港交易所及公司網站上瀏覽。該報告提供中英文版本,以符合香港交易所無紙化上市制度及電子發布公司通訊的新規定。啓明醫療鼓勵股東透過電子方式接收未來的公司通訊,並提供個人化二維碼以便股東提供電郵地址。股東若未能於2024年5月15日前提供電郵地址,將被視為同意接收公司通訊的網上版本。公司也提供選項讓股東要求以印刷本形式接收公司通訊。
Kai Ming Medical announces that its 2023 report has been published on 30 April 2024 and is available on HKEX and its corporate website. The report is available in Chinese and English to comply with the new requirements of the HKEX paperless listing system and electronic publication of corporate communications. Kai Ming Medical encourages shareholders to receive future corporate communications electronically and to provide personalized QR codes for shareholders to provide email addresses. If the shareholder fails to provide an email address by 15 May 2024, the online version of the Company's communication will be deemed to have agreed to receive the Company's communications. The Company also provides an option for shareholders to request receipt of company communications in printed form.
Kai Ming Medical announces that its 2023 report has been published on 30 April 2024 and is available on HKEX and its corporate website. The report is available in Chinese and English to comply with the new requirements of the HKEX paperless listing system and electronic publication of corporate communications. Kai Ming Medical encourages shareholders to receive future corporate communications electronically and to provide personalized QR codes for shareholders to provide email addresses. If the shareholder fails to provide an email address by 15 May 2024, the online version of the Company's communication will be deemed to have agreed to receive the Company's communications. The Company also provides an option for shareholders to request receipt of company communications in printed form.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more